3118.TWO · LEVEL
Taiwan · RS rating 53 · As of 2026-10-08
| Price | 31.30 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 46 / 57 / 50 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 27 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -20.8% |
| Sales growth Q/Q | +2.2% |
| Distance from 52-week high | +8.2% |
| Market cap (USD) | $32.0M |